BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 07, 2011
 |  BC Week In Review  |  Company News  |  Other News

Alexion, Biogen Idec, AstraZeneca, Novartis hematology, autoimmune, infectious news

Novartis filed a patent infringement suit against Alexion, Biogen Idec and AstraZeneca's MedImmune LLC subsidiary in the U.S. District Court for the District of Delaware claiming that Soliris eculizumab, Tysabri natalizumab and Synagis palivizumab from the respective...

Read the full 203 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >